Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curcumin-functionalized iron oxide nanoparticles (Cur-FeONPs) are an experimental nanomedicine platform consisting of a magnetic iron oxide (Fe3O4) core surface-modified with curcumin, a natural polyphenolic compound derived from turmeric. In this system, curcumin serves a dual role as both a therapeutic agent—providing antioxidant, anti-inflammatory, and anticancer properties—and a stabilizing or capping agent for the nanoparticles. The iron oxide core provides superparamagnetic properties, enabling the particles to be used for magnetic targeting, as contrast agents in magnetic resonance imaging (MRI), and for magnetic hyperthermia therapy. This nanoparticle formulation is specifically designed to overcome the inherent limitations of curcumin, such as its poor aqueous solubility, low bioavailability, and rapid metabolism, by enhancing its delivery to target tissues like tumor sites. Research has primarily focused on its application in various cancers, including melanoma, hepatocellular carcinoma, and cervical cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on curcumin-functionalized iron oxide nanoparticles.